Wall Street Zen upgraded shares of Avalyn Pharma (NASDAQ:AVLN – Free Report) from a sell rating to a hold rating in a research report report published on Saturday,Wall Street Zen reports. Several other brokerages have also recently issued reports on AVLN. Zacks Research upgraded shares of Avalyn Pharma to a “hold” rating in a research […]